A Phase II Study Of Single Agent Depsipeptide (FK228) In Recurrent, Platinum Sensitive Adeno-Carcinoma Of The Ovary Or Peritoneum.
Latest Information Update: 21 Dec 2016
At a glance
- Drugs Romidepsin (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Mar 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 18 Mar 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 18 Mar 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.